Saroja Pharma Industries India Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 515,200 (47%) | — | ₹433 Cr |
| Retail | — | 515,200 (47%) | — | ₹433 Cr |
| Market Maker | — | 54,400 (5%) | — | ₹5 Cr |
| Σ Total | — | 1,084,800 (100%) | — | ₹9,112 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹134,400 |
| Retail (Max) | 13 | 20,800 | ₹1,747,200 |
| S-HNI (Min) | 14 | 22,400 | ₹1,881,600 |
| B-HNI (Min) | 67 | 107,200 | ₹9,004,800 |
Financial Statements Amount in ₹ Lakhs
| Metric | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Revenue | 5,035 | 5,596 | 3,675 |
| Profit After Tax | 106 | 114 | 73 |
| Net Worth | 509 | 403 | 94 |
| Total Assets | 2,134 | 1,551 | 822 |
| Reserves & Surplus | 215 | 380 | 93 |
| Total Borrowing | 1,019 | 614 | 302 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- To Set-up a Manufacturing Unit – 7.05
- To Repay the Unsecured Loans – 1.75
Company Overview
Incorporated in 2019, Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.
The company deals in three types of product categories:
1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.
APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.
The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.
Competitive Strength:
- Experienced Promoters and Management Team
- Scalable Business Model
- Wide and diverse range of product offerings
- Diversified business operations and revenue base